Inventor · disambiguated record
Peter W. Glunz
Also filed as: GLUNZ PETER · GLUNZ PETER W · GLUNZ PETER WILLIAM
28 granted patents·4 pending applications·293 citations·filing 1998–2021
95Inventor score
Files withBRISTOL MYERS SQUIBB CO26SLOAN KETTERING INST CANCER3BRISTOL MYERS SQUIBB PHARMA CO1WURTZ NICHOLAS RONALD1
Top patents by PatentIndex Score
32 records- 0196US6653295B2Inhibitors of hepatitis C virus NS3 proteaseBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 25, 2003·81 cites·7 claims
- 0295US6727366B2Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 27, 2004·87 cites·4 claims
- 0391US11673886B25-membered and bicyclic heterocyclic amides as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jun 13, 2023·2 cites·5 claims
- 0490US11078197B25-membered and bicyclic heterocyclic amides as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 3, 2021·6 cites·16 claims
- 0586US9174974B2Macrocyclic factor VIIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 3, 2015·5 cites·9 claims
- 0682US7592331B2Macrocyclic factor VIIa inhibitors useful as anticoagulantsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 22, 2009·5 cites·25 claims
- 0782US7160856B2α-O-linked glycoconjugates, methods of preparation and uses thereofSLOAN KETTERING INST CANCER·Filed 2002·Granted Jan 9, 2007·17 cites·47 claims
- 0881US7112601B2Cycloalkyl heterocycles for treating hepatitis C virusBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Sep 26, 2006·15 cites·11 claims
- 0979US6660714B1α-O-linked glycoconjugates, methods of preparation and uses thereofSLOAN KETTERING INST CANCER·Filed 1998·Granted Dec 9, 2003·36 cites·58 claims
- 1077US7576098B2Heterocyclic compounds as inhibitors of factor VIIaBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 18, 2009·11 cites·24 claims
- 1177US7550146B2Glycopeptide conjugates and uses thereofSLOAN KETTERING INST CANCER·Filed 2004·Granted Jun 23, 2009·11 cites·69 claims
- 1276US9221767B2Substituted phthalazinones as rock inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Dec 29, 2015·2 cites·10 claims
- 1376US7122559B2Phenylglycine derivatives useful as serine protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 17, 2006·8 cites·32 claims
- 1473US10611776B2Spiroheptane salicylamides and related compounds as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 7, 2020·1 cites·17 claims
- 1569US10123993B2Cyclic ureas as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 13, 2018·2 cites·18 claims
- 1669US9902702B2Spirocycloheptanes as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 27, 2018·1 cites·15 claims
- 1766US8420830B2Macrocyclic factor VIIa inhibitors useful as anticoagulantsWURTZ NICHOLAS RONALD·Filed 2007·Granted Apr 16, 2013·2 cites·17 claims
- 1865US10787450B2Spiro-fused cyclic ureas as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 29, 2020·1 cites·13 claims
- 1958US10829501B2Spiroheptane salicylamides and related compounds as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 10, 2020·0 cites·5 claims
- 2057US9926282B2Phthalazinones and isoquinolinones as rock inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 27, 2018·0 cites·17 claims
- 2156US2009281139A1Macrocyclic factor viia inhibitors useful as anticoagulantsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 2255US10385026B2Phthalazinones and isoquinolinones as rock inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 20, 2019·0 cites·13 claims
- 2352US9458110B2Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 4, 2016·0 cites·1 claims
- 2450US2016090364A1Phthalazinones and isoquinolinones as rock inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2549US2018155296A1Spirocycloheptanes as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 2645US2004102607A1Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereofFiled 2003·Application pending·0 cites
- 2744US7094783B2Bicyclic pyrimidinones as coagulation cascade inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 22, 2006·0 cites·12 claims
- 2841US10730858B2Lactam, cyclic urea and carbamate, and triazolone derivatives as potent and selective rock inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 4, 2020·0 cites·14 claims
- 2940US10654860B2Tricyclic rho kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 19, 2020·0 cites·15 claims
- 3039US10696674B2Spirolactams as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 30, 2020·0 cites·13 claims
- 3135US10562887B2Triazolones and tetrazolones as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 18, 2020·0 cites·17 claims
- 3232US10112929B2Lactams as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 30, 2018·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Peter W. Glunz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →